Cas:425365-64-6 (9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] manufacturer & supplier

We serve Chemical Name:(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] CAS:425365-64-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime]

Chemical Name:(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime]
CAS.NO:425365-64-6
Synonyms:(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime]
Molecular Formula:C42H78N2O16
Molecular Weight:867.07252
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] Use and application,(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] technical grade,usp/ep/jp grade.


Related News: Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. (9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] manufacturer Toxic forever chemicals have no place in personal care products,” Scott Faber, EWG’s senior vice president of government affairs. “PFAS have been linked to serious health problems, including cancer and harm to the reproductive and immune systems. EWG applauds Sen. Collins and Rep. Dingell for introducing the No PFAS in Cosmetics Act. (9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] supplier Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. (9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] vendor The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774. (9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] factory Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.